Marijuana and Synthetic Cannabinoids: High-lights of the science for attorneys

Allison A. Muller
Allison A. Muller | Acri Muller Consulting, LLC

Dr. Allison Muller is a board-certified toxicologist (D.ABAT), fellow of the American Academy of Clinical Toxicology (FAACT), and registered pharmacist with over 20 years’ experience in the field of clinical toxicology. After a nearly 20-year career leading the Poison Control Center at The Children’s Hospital of Philadelphia, which included consulting on toxicology cases from 21 counties in Pennsylvania and Delaware.

Live Video-Broadcast: July 7, 2022

Marijuana and Synthetic Cannabinoids: High-lights of the science for attorneys
Accrediation Provided by:
myLawCLE
MCLE Credit Information:

Select Your State Below to View CLE Credit Information

Unable to Attend Live Broadcast?

Receive access to recorded class and earn self-study credit. Recording is made available 5 business days after live broadcast.

Can't Decide Which CLE Progam?

Access All
Federal Bar CLE Programs
co-sponsored with myLawCLE
Only $245yr

Annual Subscription includes access to:
  • 500+ Live CLE Webinars
  • National Hot Legal Topics
  • New Laws and Regulations
  • State Specific Programs
  • All Formats: Live, Replay, & On-Demand
Subscribe Today
Training 5 or more people?

Sign-up for a law firm subscription plan and each attorney in the firm receives free access to all CLE Programs

Program Summary

As marijuana sources expand to medical-use and legal recreational-use, attorneys encounter more cases involving these substances and their role in impairment. What are the differences between marijuana metabolites? What are some pearls in interpreting drug testing results? How do the various sources of marijuana (edibles, "joints", oils) differ in potency and effects on the body? What is the science behind the marijuana breath testing device? What are synthetic cannabinoids and how do they compare with marijuana? These and other questions will be answered in this one-hour presentation.

This course is co-sponsored with myLawCLE.

Key topics to be discussed:

  • State the scientific name of the parent marijuana compound and 2 major metabolites
  • Cite 2 differences between marijuana and synthetic cannabinoids
  • Identify 1 similarity between marijuana and synthetic cannabinoids
  • Provide 1 reason why determining impairment based on marijuana levels (or its metabolites) is challenging

Date / Time: July 7, 2022

  • 12:00 pm – 1:00 pm Eastern
  • 11:00 am – 12:00 pm Central
  • 10:00 am – 11:00 am Mountain
  • 9:00 am – 10:00 am Pacific

Choose a format:

Live Video Broadcast/Re-Broadcast: Watch the Program "live" in real-time, must sign-in and watch the program on the date and time set above. May ask questions during presentation via chat box. Qualifies for "live" CLE credit.

On-Demand Video: Access CLE 24/7 via the on-demand library and watch the program anytime. Qualifies for self-study CLE credit. On-demand versions are made available 5 business days after the original recording date and are viewable for up to one year.

Closed-captioning available

Speakers

Allison-A.-Muller_Acri-Muller-Consulting,-LLC_myLawCLEAllison A. Muller | Acri Muller Consulting, LLC

Dr. Allison Muller is a board-certified toxicologist (D.ABAT), fellow of the American Academy of Clinical Toxicology (FAACT), and registered pharmacist with over 20 years’ experience in the field of clinical toxicology. After a nearly 20-year career leading the Poison Control Center at The Children’s Hospital of Philadelphia, which included consulting on toxicology cases from 21 counties in Pennsylvania and Delaware, Dr. Muller is presently an independent consultant specializing in medical communications and providing expert witness testimony on cases involving medications, alcohol, chemicals, and environmental toxins. She is also adjunct faculty, teaching pharmacology and toxicology to second-year veterinary medicine students, at the University of Pennsylvania School of Veterinary Medicine.

Agenda

I. State the scientific name of the parent marijuana compound and 2 major metabolites | 12:00pm – 12:15pm

II. Cite 2 differences between marijuana and synthetic cannabinoids | 12:15pm – 12:30pm

III. Identify 1 similarity between marijuana and synthetic cannabinoids | 12:30pm – 12:45pm

IV. Provide 1 reason why determining impairment based on marijuana levels (or its metabolites) is challenging | 12:45pm -1:00pm